Consolidated Balance Sheets - USD ($)	Dec. 31, 2016	Dec. 31, 2015
Current assets
Cash and cash equivalents	$ 1,405,826	$ 2,173,258
Short term investments	0	1,651,341
Accounts receivable, trade, net of allowance for doubtful accounts of $0 at December 31, 2016 and 2015	1,193,646	929,289
Inventories	1,757,784	1,834,635
Prepaid expenses and other current assets	270,814	384,414
Total current assets	4,628,070	6,972,937
Property and equipment
Leasehold improvements	1,284,491	1,284,491
Furniture and computer equipment	650,912	557,666
Manufacturing and other equipment	922,220	1,025,521
Subtotal	2,857,623	2,867,678
Less: Accumulated depreciation	(1,670,245)	(1,421,279)
Net property and equipment	1,187,378	1,446,399
Internal use software	0	1,698,735
Intangible asset	0	2,215,385
Investment in SAVSU	2,075,000	0
Long term deposits	36,166	36,166
Total assets	7,926,614	12,369,622
Current liabilities
Accounts payable	710,719	1,029,373
Accrued expenses and other current liabilities	116,399	146,438
Accrued compensation	175,829	419,766
Deferred rent, current portion	130,216	130,216
Total current liabilities	1,133,163	1,725,793
Promissory note payable to related party, net of discount of $155,996 at December 31, 2016	2,844,004	0
Accrued interest, related party	97,857	0
Deferred rent, long term	685,450	784,458
Total liabilities	4,760,474	2,510,251
Commitments and Contingencies (Note 10)
Shareholders' equity
Common stock, $0.001 par value; 150,000,000 shares authorized, 12,863,824 and 12,448,391 shares issued and outstanding at December 31, 2016 and 2015	12,864	12,447
Additional paid-in capital	74,355,645	72,823,398
Accumulated other comprehensive loss	0	(451)
Accumulated deficit	(71,202,369)	(64,326,923)
Total BioLife Solutions, Inc. shareholders' equity	3,166,140	8,508,471
Total non-controlling interest equity	0	1,350,900
Total shareholders' equity	3,166,140	9,859,371
Total liabilities and shareholders' equity	$ 7,926,614	$ 12,369,622